Primary Health Care will sell more than 70 pathology collection centres and non-operational regional laboratories in Queensland and northern NSW to end an ACCC competition investigation.
Primary said the divestment represented about 3 per cent of its pathology collection centres and that the annual impact on profit would not be material.
Primary took over the centres and laboratories in February last year after peer Healthscope decided to close its Queensland pathology operations.
“As a result of Healthscope’s decision, Primary did not consider that the transaction would have the effect, or be likely to have the effect, of substantially lessening competition,” the company said in a release to the Australian Securities Exchange, adding that it continued to hold this view.
Primary said it would progressively divest the assets to Medlab Pathology over the course of 12 months to avoid “further loss of management time and the incurring of further costs associated with an on going ACCC investigation”.
The Australian Competition and Consumer Commission said the transaction “removed a significant third player in Queensland”, leaving just two major full-service pathology providers in that state.
ACCC chairman Rod Sims said Primary and Healthscope had completed the transaction without notifying the ACCC, “despite being on notice that the ACCC would have serious concerns about the likely competitive effect”.
Full Content: The Australian
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
T-Mobile’s Acquisition of Ka’ena Corporation Receives FCC Approval
Apr 26, 2024 by
CPI
UK Regulator Announces Two New Senior Executive Appointments
Apr 26, 2024 by
CPI
Paramount Global and Skydance Media Near Merger Deal, Eyeing CEO Change
Apr 26, 2024 by
CPI
BHP Unveils £31bn Mining Megamerger Proposal with Anglo American
Apr 25, 2024 by
nhoch@pymnts.com
ByteDance Prefers Shutdown Over Sale of TikTok Amid US Ban Threats
Apr 25, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI